$WSTRF
Western Uranium & Vanadium Corp. Stock $wstrf

$wstrf Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024033519 Filed on April 16, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$39.78K	$73.16K	$431.1K
YoY Change	-61.3%	-70.45%	-94.51%
Cost Of Revenue	$1.385M	$959.1K
YoY Change		556.05%
Gross Profit	-$1.345M	-$885.9K	$431.1K
YoY Change	-1408.67%	-974.03%	-88.7%
Gross Profit Margin	-3381.44%	-1210.93%	100.0%
Selling, General & Admin	$1.367M	$838.8K	$2.575M
YoY Change	136.67%	-41.64%	-32.79%
% of Gross Profit			597.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$151.1K	$99.61K	$262.8K
YoY Change	181.19%	1244.26%	877.91%
% of Gross Profit			60.97%
Operating Expenses	$2.752M	$838.8K	$5.527M
YoY Change	122.99%	-41.64%	20.31%
Operating Profit	-$2.712M	-$1.725M	-$5.096M
YoY Change	139.73%	29.11%	554.01%
Interest Expense	$83.60K	$34.91K	$171.2K
YoY Change	52.03%	-24.83%	90.09%
% of Operating Profit
Other Income/Expense, Net	$3.040K	-$12.59K	-$17.91K
YoY Change	-1113.33%	354.51%	-547.75%
Pretax Income	-$2.626M	-$1.702M	-$4.943M
YoY Change	143.86%	31.74%	592.46%
Income Tax
% Of Pretax Income
Net Earnings	-$2.626M	-$1.702M	-$4.943M
YoY Change	143.86%	31.74%	592.47%
Net Earnings / Revenue	-6599.94%	-2326.9%	-1146.6%
Basic Earnings Per Share	-$0.05		-$0.11
Diluted Earnings Per Share	-$0.05	-$0.04	-$0.11
COMMON SHARES
Basic Shares Outstanding	55.22M shares	44.28M shares	44.07M shares
Diluted Shares Outstanding	55.22M shares		44.07M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.817M	$9.218M	$9.218M
YoY Change	33.66%	-4.8%	-4.8%
Cash & Equivalents	$8.816M	$9.218M
Short-Term Investments	$420.00	$390.00	$390.00
Other Short-Term Assets	$45.40K	$131.3K	$588.6K
YoY Change	-59.73%	-42.33%	5.73%
Inventory
Prepaid Expenses	$170.4K	$382.3K
Receivables
Other Receivables
Total Short-Term Assets	$9.108M	$9.807M	$9.807M
YoY Change	31.54%	-4.23%	-4.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.69M	$14.93M	$14.93M
YoY Change	8.82%	16.62%	16.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$676.4K	$676.4K	$676.4K
YoY Change	0.01%	0.0%	0.0%
Total Long-Term Assets	$25.86M	$25.09M	$25.09M
YoY Change	5.17%	9.26%	9.26%
TOTAL ASSETS
Total Short-Term Assets	$9.108M	$9.807M	$9.807M
Total Long-Term Assets	$25.86M	$25.09M	$25.09M
Total Assets	$34.96M	$34.90M	$34.90M
YoY Change	10.97%	5.1%	5.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$626.1K	$562.8K	$562.8K
YoY Change	25.64%	39.41%	39.41%
Accrued Expenses	$144.4K	$198.3K	$198.3K
YoY Change	-11.89%	34.06%	34.06%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$845.6K	$836.2K	$836.2K
YoY Change	12.92%	24.7%	24.7%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$582.2K	$582.2K	$582.2K
YoY Change	3.24%	2.96%	2.96%
Total Long-Term Liabilities	$582.2K	$582.2K	$582.2K
YoY Change	3.24%	2.96%	2.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$845.6K	$836.2K	$836.2K
Total Long-Term Liabilities	$582.2K	$582.2K	$582.2K
Total Liabilities	$4.137M	$4.127M	$4.127M
YoY Change	2.86%	4.62%	4.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.92M	-$18.82M
YoY Change	48.99%	35.62%
Common Stock	$55.03M	$49.66M
YoY Change	25.79%	14.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$30.83M	$30.77M	$30.77M
YoY Change
Total Liabilities & Shareholders Equity	$34.96M	$34.90M	$34.90M
YoY Change	10.97%	5.1%	5.1%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.626M	-$1.702M	-$4.943M
YoY Change	143.86%	31.74%	592.47%
Depreciation, Depletion And Amortization	$151.1K	$99.61K	$262.8K
YoY Change	181.19%	1244.26%	877.91%
Cash From Operating Activities	-$2.029M	-$1.526M	-$4.089M
YoY Change	155.05%	144.47%	-189.87%
INVESTING ACTIVITIES
Capital Expenditures	$626.6K	$530.3K	$2.404M
YoY Change	-42.78%	252.94%	129.95%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$626.6K	-$530.3K	-$2.404M
YoY Change	-42.78%	252.94%	129.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	5.293M	$5.844M
YoY Change			3.77%
NET CHANGE
Cash From Operating Activities	-2.029M	-1.526M	-$4.089M
Cash From Investing Activities	-626.6K	-530.3K	-$2.404M
Cash From Financing Activities	0.000	5.293M	$5.844M
Net Change In Cash	-2.655M	3.236M	-$464.5K
YoY Change	40.46%	-517.84%	-105.27%
FREE CASH FLOW
Cash From Operating Activities	-$2.029M	-$1.526M	-$4.089M
Capital Expenditures	$626.6K	$530.3K	$2.404M
Free Cash Flow	-$2.655M	-$2.056M	-$6.494M
YoY Change	40.46%	165.51%	-285.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2022Q4	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-55626
CY2023	dei	Entity Registrant Name EntityRegistrantName	WESTERN URANIUM & VANADIUM CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A6
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	330 Bay Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1400
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Toronto
CY2023	dei	Entity Address Country EntityAddressCountry	CA
CY2023	dei	City Area Code CityAreaCode	(970)
CY2023	dei	Local Phone Number LocalPhoneNumber	864-2125
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34897323	usd
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	29600000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55223113	shares
CY2023	dei	Auditor Firm AuditorFirmId	1930
CY2023	dei	Auditor Name AuditorName	MNP LLP
CY2023	dei	Auditor Location AuditorLocation	Mississauga, Canada
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9217585	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9682133	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	75075	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	75057	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	382314	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	254105	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	385	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	612	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	131255	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	227588	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9806614	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10239495	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	676369	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	676348	usd
CY2023Q4	wstrf	Property Plant Equipment And Mineral Properties Net PropertyPlantEquipmentAndMineralPropertiesNet	14926289	usd
CY2022Q4	wstrf	Property Plant Equipment And Mineral Properties Net PropertyPlantEquipmentAndMineralPropertiesNet	12798904	usd
CY2023Q4	wstrf	Ablation Intellectual Property AblationIntellectualProperty	9488051	usd
CY2022Q4	wstrf	Ablation Intellectual Property AblationIntellectualProperty	9488051	usd
CY2023Q4	us-gaap	Assets Assets	34897323	usd
CY2022Q4	us-gaap	Assets Assets	33202798	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	761123	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	551615	usd
CY2023Q4	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	75057	usd
CY2022Q4	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	75057	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	43860	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	836180	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	670532	usd
CY2023Q4	us-gaap	Mine Reclamation And Closing Liability Noncurrent MineReclamationAndClosingLiabilityNoncurrent	241562	usd
CY2022Q4	us-gaap	Mine Reclamation And Closing Liability Noncurrent MineReclamationAndClosingLiabilityNoncurrent	225219	usd
CY2023Q4	wstrf	Deferred Tax Liability DeferredTaxLiability	2708887	usd
CY2022Q4	wstrf	Deferred Tax Liability DeferredTaxLiability	2708887	usd
CY2023Q4	wstrf	Deferred Contingent Considerations DeferredContingentConsiderations	340650	usd
CY2022Q4	wstrf	Deferred Contingent Considerations DeferredContingentConsiderations	340252	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4127279	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3944890	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50002395	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43602871	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50002089	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43602565	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	49661910	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	43394303	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	306	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	306	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18817857	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13875263	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-74009	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33202798	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-261132	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	30770044	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29257908	usd
CY2023	us-gaap	Revenues Revenues	431065	usd
CY2022	us-gaap	Revenues Revenues	7858972	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	4044083	usd
CY2023	us-gaap	Gross Profit GrossProfit	431065	usd
CY2022	us-gaap	Gross Profit GrossProfit	3814889	usd
CY2023	wstrf	Mining Expenditure MiningExpenditure	2951579	usd
CY2022	wstrf	Mining Expenditure MiningExpenditure	762333	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	386473	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	493940	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1884456	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3246171	usd
CY2023	wstrf	Consulting Fees ConsultingFees	304457	usd
CY2022	wstrf	Consulting Fees ConsultingFees	91626	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	5526965	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4594070	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-5095900	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-779181	usd
CY2023	wstrf	Accretion And Interestincome Expense Net AccretionAndInterestincomeExpenseNet	158904	usd
CY2022	wstrf	Accretion And Interestincome Expense Net AccretionAndInterestincomeExpenseNet	61414	usd
CY2023	us-gaap	Other Income OtherIncome	-5598	usd
CY2022	us-gaap	Other Income OtherIncome	4000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4942594	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-713767	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	187123	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-324610	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4755471	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1038377	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44073655	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42815086	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23097492	usd
CY2022	wstrf	Stock Issued During Value Private Placement Net Of Offering Costs StockIssuedDuringValuePrivatePlacementNetOfOfferingCosts	3011878	usd
CY2022	wstrf	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2620395	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1566520	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-324610	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-713767	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29257908	usd
CY2023	wstrf	Stock Issued During Value Private Placement Net Of Offering Costs StockIssuedDuringValuePrivatePlacementNetOfOfferingCosts	4836867	usd
CY2023	wstrf	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1004044	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	426696	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	187123	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4942594	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	30770044	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4942594	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-713767	usd
CY2023	us-gaap	Depreciation Depreciation	262832	usd
CY2022	us-gaap	Depreciation Depreciation	26877	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5598	usd
CY2023	wstrf	Accretion Of Reclamation Liability AccretionOfReclamationLiability	12308	usd
CY2022	wstrf	Accretion Of Reclamation Liability AccretionOfReclamationLiability	28656	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	429429	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1566520	usd
CY2023	wstrf	Change In Marketable Securities ChangeInMarketableSecurities	227	usd
CY2022	wstrf	Change In Marketable Securities ChangeInMarketableSecurities	1508	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4085723	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	27376	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	63953	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	209508	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-147979	usd
CY2022	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers	-146177	usd
CY2023	wstrf	Increase Decrease In Reclamation Liability IncreaseDecreaseInReclamationLiability	-4035	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-43860	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-64620	usd
CY2023	wstrf	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	-398	usd
CY2022	wstrf	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	22542	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4089495	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4550246	usd
CY2023	us-gaap	Payments To Acquire Mining Assets PaymentsToAcquireMiningAssets	2404440	usd
CY2022	us-gaap	Payments To Acquire Mining Assets PaymentsToAcquireMiningAssets	1045638	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2404440	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1045638	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4836867	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3011878	usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1004044	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2620395	usd
CY2023	wstrf	Proceeds From Saleand Collectionof Note Receivable ProceedsFromSaleandCollectionofNoteReceivable	3500	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5844411	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5632273	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	185015	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-324610	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-464509	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8812271	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10433538	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1621267	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9969029	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10433538	usd
CY2023Q4	us-gaap	Cash Cash	9217585	usd
CY2022Q4	us-gaap	Cash Cash	9682133	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	75075	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	75057	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	676369	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	676348	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9969029	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10433538	usd
CY2023	wstrf	Notes Received In Exchange For Equipment Sold NotesReceivedInExchangeForEquipmentSold	8000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4942594	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-713767	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18817857	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13875263	usd
CY2023	wstrf	Working Capital WorkingCapital	8970434	usd
CY2022	wstrf	Working Capital WorkingCapital	9568963	usd
CY2023Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5215828	shares
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.39
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	7250000	cad
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4836867	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1004044	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. By their nature, these estimates are subject to measurement uncertainty, and the effects on the consolidated financial statements of changes in such estimates in future periods could be significant. Significant areas requiring management’s estimates and assumptions include the determination of the fair value of transactions involving common shares, assessment of the useful life and evaluation for impairment of Kinetic Separation intellectual property, valuation and impairment assessments of mineral properties and equipment, valuation of deferred contingent consideration, valuation of the reclamation liability and valuation of stock-based compensation. Other areas requiring estimates include allocations of expenditures, depletion, and amortization of mineral rights and properties. Actual results could differ from those estimates.</p>
CY2023	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	more than 50 percent
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15722205	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13668410	shares
CY2023Q4	wstrf	Property Plant And Equipment And Mineral Properties Gross PropertyPlantAndEquipmentAndMineralPropertiesGross	15247940	usd
CY2022Q4	wstrf	Property Plant And Equipment And Mineral Properties Gross PropertyPlantAndEquipmentAndMineralPropertiesGross	12863400	usd
CY2023Q4	wstrf	Accumulated Depreciation Property Plant And Equipment And Mineral Properties AccumulatedDepreciationPropertyPlantAndEquipmentAndMineralProperties	321651	usd
CY2022Q4	wstrf	Accumulated Depreciation Property Plant And Equipment And Mineral Properties AccumulatedDepreciationPropertyPlantAndEquipmentAndMineralProperties	64496	usd
CY2023Q4	wstrf	Property Plant And Equipment And Mineral Properties Net PropertyPlantAndEquipmentAndMineralPropertiesNet	14926289	usd
CY2022Q4	wstrf	Property Plant And Equipment And Mineral Properties Net PropertyPlantAndEquipmentAndMineralPropertiesNet	12798904	usd
CY2023Q4	wstrf	Kinetic Separation Intellectual Property KineticSeparationIntellectualProperty	9488051	usd
CY2022Q4	wstrf	Kinetic Separation Intellectual Property KineticSeparationIntellectualProperty	9488051	usd
CY2023	us-gaap	Payments To Acquire Mining Assets PaymentsToAcquireMiningAssets	2404440	usd
CY2022	us-gaap	Payments To Acquire Mining Assets PaymentsToAcquireMiningAssets	1045638	usd
CY2023	us-gaap	Depreciation Depreciation	262832	usd
CY2022	us-gaap	Depreciation Depreciation	26877	usd
CY2023Q4	us-gaap	Area Of Land AreaOfLand	160	sqm
CY2023	us-gaap	Operating Leases Of Lessor Contingent Rentals Description Of Variable Rate Basis OperatingLeasesOfLessorContingentRentalsDescriptionOfVariableRateBasis	As consideration for entering into the lease, the lessee has agreed to pay the Company a royalty from the lessee’s revenue attributed to oil and gas produced, saved, and sold attributable to the net mineral interest.
CY2023	us-gaap	Payments To Acquire Royalty Interests In Mining Properties PaymentsToAcquireRoyaltyInterestsInMiningProperties	431065	usd
CY2022	us-gaap	Payments To Acquire Royalty Interests In Mining Properties PaymentsToAcquireRoyaltyInterestsInMiningProperties	635363	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	751444	usd
CY2022Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	751405	usd
CY2023Q4	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	75057	usd
CY2023	wstrf	Reclamation Liability Discount Rate ReclamationLiabilityDiscountRate	0.054	pure
CY2023Q4	us-gaap	Mine Reclamation And Closing Liability Noncurrent MineReclamationAndClosingLiabilityNoncurrent	241562	usd
CY2022Q4	us-gaap	Mine Reclamation And Closing Liability Noncurrent MineReclamationAndClosingLiabilityNoncurrent	225219	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	300276	usd
CY2021Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	271620	usd
CY2023	wstrf	Increase Decrease In Reclamation Liability IncreaseDecreaseInReclamationLiability	-4035	usd
CY2023	wstrf	Accretion Of Reclamation Liability AccretionOfReclamationLiability	12308	usd
CY2022	wstrf	Accretion Of Reclamation Liability AccretionOfReclamationLiability	28656	usd
CY2023Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	316619	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	300276	usd
CY2023Q4	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	75057	usd
CY2022Q4	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	75057	usd
CY2023Q4	us-gaap	Mine Reclamation And Closing Liability Noncurrent MineReclamationAndClosingLiabilityNoncurrent	241562	usd
CY2022Q4	us-gaap	Mine Reclamation And Closing Liability Noncurrent MineReclamationAndClosingLiabilityNoncurrent	225219	usd
CY2023	wstrf	Kinetic Separation Intellectual Property Description KineticSeparationIntellectualPropertyDescription	The Kinetic Separation intellectual property was acquired in Western’s acquisition of Black Range on September 16, 2015. Previously Black Range acquired its Kinetic Separation assets in the dissolution of a joint venture on March 17, 2015, through the acquisition of all the assets of the joint venture and received a 25-year license to utilize all of the patented and unpatented technology owned by the joint venture. The technology license agreement for patents and unpatented technology became effective as of March 17, 2015, for a period of 25 years, until March 16, 2040.
CY2014Q1	wstrf	Patent Term PatentTerm	P20Y
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	562831	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	403705	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	198292	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	147910	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	761123	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	551615	usd
CY2021Q2	us-gaap	Other Commitment OtherCommitment	78000	usd
CY2022Q2	wstrf	Uranium Conentrates UraniumConentrates	125000	lb
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7223609	usd
CY2022	wstrf	Uranium Price Per Pound UraniumPricePerPound	57
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	4044083	usd
CY2021Q2	wstrf	Pounds Of Uranium PoundsOfUranium	125000	lb
CY2021Q2	wstrf	Pounds Of Uranium Purchased PoundsOfUraniumPurchased	32	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	4044083	usd
CY2021	wstrf	Pounds Of Uranium PoundsOfUranium	125000	lb
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	153247	cad
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	122539	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.5
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	661912	cad
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	488122	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.88
CY2023	wstrf	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1004044	usd
CY2022	wstrf	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2620395	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50002089	shares
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.6
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.17
CY2022	wstrf	Cashless Exercise Of Stock Options CashlessExerciseOfStockOptions	50000	shares
CY2023	wstrf	Cashless Exercise Of Stock Options CashlessExerciseOfStockOptions	50000	shares
CY2023Q4	us-gaap	Share Price SharePrice	1.56
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.6
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0406	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y7M6D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.72
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.72
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	429429	usd
CY2023Q4	wstrf	Unamortized Stock Option Expense UnamortizedStockOptionExpense	975101	usd
CY2022Q4	wstrf	Unamortized Stock Option Expense UnamortizedStockOptionExpense	364095	usd
CY2023	wstrf	Mining Costs MiningCosts	1453063	usd
CY2022	wstrf	Mining Costs MiningCosts	471622	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1383074	usd
CY2023	wstrf	Payments To Acquire Mining Permits PaymentsToAcquireMiningPermits	107989	usd
CY2022	wstrf	Payments To Acquire Mining Permits PaymentsToAcquireMiningPermits	282851	usd
CY2023	wstrf	Royalties Royalties	7453	usd
CY2022	wstrf	Royalties Royalties	7860	usd
CY2023	wstrf	Mining Expenditure MiningExpenditure	2951579	usd
CY2022	wstrf	Mining Expenditure MiningExpenditure	762333	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	340650	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	340252	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	71700	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	55198	usd
CY2023	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	25800	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6985894	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5708411	usd
CY2023Q4	wstrf	Deferred Tax Assets Marketable Securities DeferredTaxAssetsMarketableSecurities	13646	usd
CY2022Q4	wstrf	Deferred Tax Assets Marketable Securities DeferredTaxAssetsMarketableSecurities	16094	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	35681	usd
CY2023Q4	wstrf	Deferred Tax Assets Exploration Amortization DeferredTaxAssetsExplorationAmortization	925249	usd
CY2022Q4	wstrf	Deferred Tax Assets Exploration Amortization DeferredTaxAssetsExplorationAmortization	725959	usd
CY2023Q4	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	20192	usd
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	64761	usd
CY2023Q4	wstrf	Deferred Tax Assets Accretion Expense DeferredTaxAssetsAccretionExpense	9899	usd
CY2022Q4	wstrf	Deferred Tax Assets Accretion Expense DeferredTaxAssetsAccretionExpense	8639	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7954880	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6559545	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5602952	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3688584	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2351928	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2870961	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4758757	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5314338	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	302058	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	265510	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2708887	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2708887	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3688584	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3488821	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1914368	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	199763	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5602952	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3688584	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.038	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.019	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.374	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies Other EffectiveIncomeTaxRateReconciliationTaxContingenciesOther	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies Other EffectiveIncomeTaxRateReconciliationTaxContingenciesOther	-0.01	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.244	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.329	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.403	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.193	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.032	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5602952	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3688584	usd
CY2023	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	Internal Revenue Code (“IRC”) Section 382 imposes limitations on the use of net operating loss carryovers when the share ownership of one or more 5% shareholders (shareholders owning 5% or more of the Company’s outstanding capital stock) has increased on a cumulative basis over a period of three years by more than 50 percentage points.
CY2023	wstrf	Working Capital WorkingCapital	8970434	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9217585	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2023	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42815086	shares
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers		usd
CY2022	wstrf	Increase Decrease In Reclamation Liability IncreaseDecreaseInReclamationLiability		usd
CY2022	wstrf	Proceeds From Saleand Collectionof Note Receivable ProceedsFromSaleandCollectionofNoteReceivable		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	wstrf	Notes Received In Exchange For Equipment Sold NotesReceivedInExchangeForEquipmentSold		usd
CY2022	wstrf	Increase Decrease In Reclamation Liability IncreaseDecreaseInReclamationLiability		usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense		usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001621906
CY2023	dei	Security Exchange Name SecurityExchangeName	NONE
CY2023	dei	Trading Symbol TradingSymbol	WSTRF

Files In Submission

Name	View Source	Status
0001213900-24-033519-index-headers.html	Edgar Link	pending
0001213900-24-033519-index.html	Edgar Link	pending
0001213900-24-033519.txt	Edgar Link	pending
0001213900-24-033519-xbrl.zip	Edgar Link	pending
ea0203654-10k_western.htm	Edgar Link	pending
ea020365401ex21-1_western.htm	Edgar Link	pending
ea020365401ex31-1_western.htm	Edgar Link	pending
ea020365401ex31-2_western.htm	Edgar Link	pending
ea020365401ex32-1_western.htm	Edgar Link	pending
ea020365401ex95_western.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0203654-10k_western_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wstrf-20231231.xsd	Edgar Link	pending
wstrf-20231231_def.xml	Edgar Link	unprocessable
wstrf-20231231_lab.xml	Edgar Link	unprocessable
wstrf-20231231_pre.xml	Edgar Link	unprocessable
wstrf-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WSTRF
Western Uranium & Vanadium Corp. Stock $wstrf

2024 Q2 Form 10-K Financial Statement

#000121390024033519 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WSTRF Western Uranium & Vanadium Corp. Stock $wstrf

2024 Q2 Form 10-K Financial Statement

#000121390024033519 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WSTRF
Western Uranium & Vanadium Corp. Stock $wstrf